Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
A phase 3 trial of Clofarabine, Cyclophosphamide, Cytarabine, Dasatinib, Daunorubicin, Dexamethasone, Doxorubicin, Etoposide, Leucovorin, Mercaptopurine, Methotrexate, Asparaginase, Prednisone, Thioguanine and Vincristine in Acute lymphoblastic leukaemia and Leukaemia, run by National Cancer Institute (NCI), completed.
Overview
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations is a phase 3 interventional study registered as NCT02883049 by National Cancer Institute (NCI), with 5949 participants recorded, started 2012-02-29 and reaching its primary completion in 2022-12-31. Interventions recorded: Clofarabine, Cyclophosphamide, Cytarabine, Dasatinib, Daunorubicin Hydrochloride, Dexamethasone, Doxorubicin Hydrochloride, Etoposide, Hydrocortisone Sodium Succinate, Laboratory Biomarker Analysis, Leucovorin Calcium, Mercaptopurine, Methotrexate, Pegaspargase, Prednisone, Radiation Therapy, Thioguanine, Vincristine Sulfate. Conditions recorded: B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Central Nervous System Leukemia, Testicular Leukemia.
Linked to the drug Clofarabine because the registry names it among its interventions and Acute lymphoblastic leukaemia and Leukaemia among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialCombination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Shares Mercaptopurine, Asparaginase (pegaspargase, calaspargase pegol, Erwinia asparaginase), Daunorubicin, Leucovorin (folinic acid) and the tag pipeline.
- TrialInternational Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Shares Thioguanine, Mercaptopurine, Daunorubicin, Cytarabine and the tag pipeline.
- TrialInotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Shares Thioguanine, Mercaptopurine, Daunorubicin, Cytarabine and the tag pipeline.
- TrialTherapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma
Shares Clofarabine, Mercaptopurine, Asparaginase (pegaspargase, calaspargase pegol, Erwinia asparaginase), Cytarabine and the tag pipeline.
- TrialTreatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
Shares Daunorubicin, Cytarabine, Leukaemia (all types), Prednisone and the tag pipeline.
- TrialRituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
Shares Leucovorin (folinic acid), Cytarabine, Prednisone, Methotrexate and the tag pipeline.
- TrialTreatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
Shares Cytarabine, Prednisone, Methotrexate, Dexamethasone and the tag pipeline.
- TrialResponse-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Shares Thioguanine, Asparaginase (pegaspargase, calaspargase pegol, Erwinia asparaginase), Daunorubicin, Cytarabine and the tag pipeline.